1. Home
  2. MAIA vs DALN Comparison

MAIA vs DALN Comparison

Compare MAIA & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • DALN
  • Stock Information
  • Founded
  • MAIA 2018
  • DALN 1954
  • Country
  • MAIA United States
  • DALN United States
  • Employees
  • MAIA N/A
  • DALN N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • DALN Newspapers/Magazines
  • Sector
  • MAIA Health Care
  • DALN Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • DALN Nasdaq
  • Market Cap
  • MAIA 44.8M
  • DALN 38.1M
  • IPO Year
  • MAIA 2022
  • DALN 2008
  • Fundamental
  • Price
  • MAIA $1.48
  • DALN $4.41
  • Analyst Decision
  • MAIA
  • DALN
  • Analyst Count
  • MAIA 0
  • DALN 0
  • Target Price
  • MAIA N/A
  • DALN N/A
  • AVG Volume (30 Days)
  • MAIA 124.0K
  • DALN 52.5K
  • Earning Date
  • MAIA 05-13-2025
  • DALN 05-13-2025
  • Dividend Yield
  • MAIA N/A
  • DALN N/A
  • EPS Growth
  • MAIA N/A
  • DALN N/A
  • EPS
  • MAIA N/A
  • DALN 0.02
  • Revenue
  • MAIA N/A
  • DALN $125,391,000.00
  • Revenue This Year
  • MAIA N/A
  • DALN N/A
  • Revenue Next Year
  • MAIA N/A
  • DALN N/A
  • P/E Ratio
  • MAIA N/A
  • DALN $228.00
  • Revenue Growth
  • MAIA N/A
  • DALN N/A
  • 52 Week Low
  • MAIA $1.46
  • DALN $2.98
  • 52 Week High
  • MAIA $5.99
  • DALN $7.86
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 35.67
  • DALN 26.30
  • Support Level
  • MAIA $1.52
  • DALN $4.40
  • Resistance Level
  • MAIA $1.95
  • DALN $6.31
  • Average True Range (ATR)
  • MAIA 0.11
  • DALN 0.46
  • MACD
  • MAIA -0.01
  • DALN -0.17
  • Stochastic Oscillator
  • MAIA 5.09
  • DALN 0.30

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.

Share on Social Networks: